Zelenectide Pevedotin in NECTIN4 Amplified Advanced or Metastatic Non-small Cell Lung Cancer
A phase 2 trial of Zelenectide pevedotin in non-small-cell lung cancer and small-cell lung cancer, run by BicycleTx Limited, active and no longer recruiting.
Overview
Zelenectide Pevedotin in NECTIN4 Amplified Advanced or Metastatic Non-small Cell Lung Cancer is a phase 2 interventional study registered as NCT06933329 by BicycleTx Limited, with 73 participants planned, started 2025-07-18 and due to reach its primary completion in 2028-08-31. Interventions recorded: Zelenectide pevedotin. Conditions listed: Non-Small Cell Lung Cancer. No results are recorded here; the registry entry is the source.
Setting
Phase 2 Study of Zelenectide Pevedotin in Participants With Previously-Treated NECTIN4 Amplified Advanced or Metastatic Non-small Cell Lung Cancer
Phase
Phase 2
Sponsor
BicycleTx Limited
Registry
Enrolled
73
Similar pages
not linked directly; found by shared links- TrialStudy BT5528-100 in Patients With Advanced Solid Tumors Associated With EphA2 Expression
Shares Bicycle Therapeutics, Small-cell lung cancer, Non-small-cell lung cancer.
- TrialStudy BT8009-100 in Subjects With Nectin-4 Expressing Advanced Malignancies
- TechnologyPeptide-drug & small-molecule-drug conjugates